AFJK — Aimei Health Technology Co Share Price
Last trade - 00:00- $67.52m
- $67.72m
- 25
- 53
- 48
- 37
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.93 | ||
| Price to Tang. Book | 0.93 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.46% | ||
| Return on Equity | 3.59% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +1388.99 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 27th, 2023
- Public Since
- January 22nd, 2024
- No. of Shareholders
- 10
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- NASDAQ Global Market
- Shares in Issue
- 6,121,733
- Address
- 10 East 53Rd Street, Suite 3001, NEW YORK, 10022
- Web
- Phone
- Auditors
- Malone Bailey, LLP
Similar to AFJK
Agriculture & Natural Solutions Acquisition
NASDAQ Global Market
Agriculture & Natural Solutions Acquisition
NASDAQ Global Market
Aifeex Nexus Acquisition
NASDAQ Global Market
Aifeex Nexus Acquisition
NASDAQ Global Market
Aimei Health Technology Co
NASDAQ Global Market
FAQ
As of Today at 19:08 UTC, shares in Aimei Health Technology Co are trading at $11.03. This share price information is delayed by 15 minutes.
Shares in Aimei Health Technology Co last closed at $11.03 and the price had moved by +7.4% over the past 365 days. In terms of relative price strength the Aimei Health Technology Co share price has underperformed the S&P500 Index by -0.87% over the past year.
There is no consensus recommendation for this security.
Find out moreAimei Health Technology Co does not currently pay a dividend.
Aimei Health Technology Co does not currently pay a dividend.
Aimei Health Technology Co does not currently pay a dividend.
To buy shares in Aimei Health Technology Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $11.03, shares in Aimei Health Technology Co had a market capitalisation of $67.52m.
Here are the trading details for Aimei Health Technology Co:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: AFJK
Based on an overall assessment of its quality, value and momentum Aimei Health Technology Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aimei Health Technology Co. Over the past six months, its share price has outperformed the S&P500 Index by +10.51%.
As of the last closing price of $11.03, shares in Aimei Health Technology Co were trading +4.95% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aimei Health Technology Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $11.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Aimei Health Technology Co's directors